RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis Amplification therapies—today announced ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics—the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central nervous ...
On Oct. 10, the Schroeder Lab, led by Prof. Frank Schroeder, chemistry and chemical biology, published a study detailing a new class of serotonin-containing compounds and another serotonin pathway in ...
The intricate web of chemical messengers that facilitate communication between neurons represents one of the body’s most complex and fascinating systems. These neurotransmitters, including serotonin, ...
In a report scheduled for publication in the June 2023 issue of the Journal of Affective Disorders, researchers explore the association between the gut microbiome and the efficacy of selective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results